Article Data

  • Views 1374
  • Dowloads 156

Case Reports

Open Access

A case of Fahr disease with transient slurred speech and abnormal movement of the left arm

  • Haewon Jung1
  • Jae Yun Ahn1,*,
  • Jae Wan Cho1
  • Sungbae Moon1
  • Hyun Wook Ryoo1

1Department of Emergency Medicine, School of Medicine, Kyungpook National University, 41944 Daegu, Republic of Korea

DOI: 10.22514/sv.2023.066 Vol.19,Issue 4,July 2023 pp.213-216

Submitted: 12 May 2022 Accepted: 28 June 2022

Published: 08 July 2023

*Corresponding Author(s): Jae Yun Ahn E-mail: jyahn@knu.ac.kr

Abstract

Fahr disease is a rare neurological condition characterized by abnormal basal ganglia calcification. Some patients with Fahr disease have been reported to present to the emergency department (ED) with stroke-like symptoms. Here, we present a case of Fahr disease with transient focal neurological signs. A 63-year-old man came to the ED with complaints of slurred speech and abnormal movement of his left arm. His symptoms lasted only 5 minutes before he recovered. He had no focal neurological deficits when he arrived at the ED, had no previous medical history and had never taken any medication. A physical examination revealed that the patient was healthy, and the initial results of laboratory tests were all within normal range. A brain computed tomography (CT) without contrast enhancement revealed symmetric calcification of the basal ganglia, thalamus and dentate nucleus of the cerebellum. Magnetic resonance imaging of the brain and neck CT angiography revealed no evidence of acute cerebral infarction, intracranial large-vessel occlusion, or stenosis. Based on his clinical presentation and examination results, the patient was diagnosed with Fahr disease in the ED. He was recommended to be admitted for differential diagnosis of seizures and additional tests, such as electroencephalography, but opted for discharge against medical advice. Emergency physicians should consider the possibility of Fahr disease if patients have focal neurological signs with characteristic symmetric calcification on brain CT. A detailed history and examination should be performed to detect other secondary causes associated with Fahr syndrome.


Keywords

Fahr disease; Basal ganglia calcification; Computed tomography


Cite and Share

Haewon Jung,Jae Yun Ahn,Jae Wan Cho,Sungbae Moon,Hyun Wook Ryoo. A case of Fahr disease with transient slurred speech and abnormal movement of the left arm. Signa Vitae. 2023. 19(4);213-216.

References

[1] Alam ST, Aswani Y, Anandpara KM, Hira P. CT findings in Fahr’s disease. Case Reports. 2015; 2015: bcr2014208812.

[2] Donzuso G, Mostile G, Nicoletti A, Zappia M. Basal ganglia calci-fications (Fahr’s syndrome): related conditions and clinical features. Neurological Sciences. 2019; 40: 2251–2263.

[3] Saleem S, Aslam HM, Anwar M, Anwar S, Saleem M, Saleem A, et al. Fahr’s syndrome: literature review of current evidence. Orphanet Journal of Rare Diseases. 2013; 8: 156.

[4] Modrego P, Mojonero J, Serrano M, Fayed N. Fahr’s syndrome presenting with pure and progressive presenile dementia. Neurological Sciences. 2005; 26: 367–369.

[5] G J, Bansal R, Ajmal M, Gupta P, Pathania M. Young male with seizure disorder and intracranial calcification: a case of Fahr’s syndrome. Cureus. 2022; 14: e22189.

[6] Yang C, Lo C, Wu M. Ischemic stroke in a young patient with Fahr’s disease: a case report. BMC Neurology. 2016; 16: 33.

[7] Harrington MG, Macpherson P, McIntosh WB, Allam BF, Bone I. The significance of the incidental finding of basal ganglia calcification on computed tomography. Journal of Neurology, Neurosurgery & Psychiatry. 1981; 44: 1168–1170.

[8] Kim T, Park I, Kim S, Lee K, Kim Y, Kim J. Striopallidodentate calcification and progressive supranuclear palsy-like phenotype in a patient with idiopathic hypoparathyroidism. Journal of Clinical Neurology. 2007; 3: 57.

[9] Otu AA, Anikwe JC, Cocker D. Fahr’s disease: a rare neurological presentation in a tropical setting. Clinical Case Reports. 2015; 3: 806–808.

[10] Shouyama M, Kitabata Y, Kaku T, Shinosaki K. Evaluation of regional cerebral blood flow in Fahr disease with schizophrenia-like psychosis: a case report. American Journal of Neuroradiology. 2005; 26: 2527–2529.

[11] Sava A, Dumitrescu G, Haba D, Hodorog D, Mihailov C, Şapte E. The Fahr syndrome and the chronic lymphocytic thyroiditis. Romanian Journal of Morphology and Embryology. 2013; 54: 195–200.

[12] Uygur G, Liu Y, Hellman R, Tikofsky R, Collier B. Evaluation of regional cerebral blood flow in massive intracerebral calcifications. Journal of Nuclear Medicine. 1995; 36: 610–612.

[13] Yang C, Lo C, Wu M. Ischemic stroke in a young patient with Fahr’s disease: a case report. BMC Neurology. 2016; 16: 33.

[14] Jaworski K, Styczyńska M, Mandecka M, Walecki J, Kosior DA. Fahr syndrome—an important piece of a puzzle in the differential diagnosis of many diseases. Polish Journal of Radiology. 2017; 82: 490–493.

[15] Amisha F, Munakomi S. Fahr syndrome. StatPearls: Treasure Island (FL). 2022.

[16] Asensio Moreno C, Arias Jiménez JL, Aramburu Bodas O, Ortega Calvo M, Pérez Cano R. Transient ischemic attack associated with a calcinosis cerebri syndrome. Anales de Medicina Interna. 2008; 25: 33–35. (In Spanish)

[17] Govindarajan A. Imaging in Fahr’s disease: how CT and MRI differ?Case Reports. 2013; 2013: bcr2013201523.

[18] Sahin N, Solak A, Genc B, Kulu U. Fahr disease: use of susceptibility-weighted imaging for diagnostic dilemma with magnetic resonance imaging. Quantitative Imaging in Medicine and Surgery. 2015; 5: 628–632.

[19] Rastogi R, Singh A, Rastogi U, Mohan C, Rastogi V. Fahr’s syndrome: a rare clinico-radiologic entity. Medical Journal Armed Forces India. 2011; 67: 159–161.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top